Background A discrepancy often exists between the post-neoadjuvant chemotherapy (NAC)
breast tumor size on magnetic resonance imaging (MRI) and pathologic tumor size. We seek …

Background Neoadjuvant chemotherapy precludes the accurate pre‐surgical pathologic
measurement of tumor size. The purpose of this study is to review imaging studies …

Objective: The aim of this study was to establish an magnetic resonance imaging (MRI)-
based interpretation model to facilitate the selection of breast-conserving surgery (BCS) after …

BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in
evaluation of pathologically complete response and residual tumors in patients who were …

Magnetic resonance imaging (MRI) is highly sensitive in identifying residual breast cancer
following neoadjuvant chemotherapy (NAC), and consequently is a commonly used imaging …

Objective: To investigate whether the accuracy of magnetic resonance imaging (MRI) after
neoadjuvant systemic therapy (NST) is affected by molecular features of primary breast …

Purpose To evaluate the relevance of breast cancer subtypes for magnetic resonance
imaging (MRI) markers for monitoring of therapy response during neoadjuvant …

Purpose The purpose of this study was to evaluate the accuracy of breast magnetic
resonance imaging (MRI) to predict residual lesion size after neoadjuvant chemotherapy …

Abstract Background and Objectives To investigate accuracy of magnetic resonance
imaging (MRI) for measuring residual tumor size in breast cancer patients receiving …

Background This study assessed whether magnetic resonance imaging (MRI) could
accurately predict pathologic complete response (pCR) after neoadjuvant chemotherapy …